A big part of this businesses model is because only large Pharma companies are e...

s1artibartfast 6 months ago | parent | context | favorite | on: FDA approves a novel drug for schizophrenia

A big part of this businesses model is because only large Pharma companies are equipped to handle the regulatory barriers and large enough to negotiate with the PBMs